Illumina Inc. Logo

Illumina Inc. (ILU)

FSX

Currency in EUR
229.15
-5.65 (-2.41%)

Real-time Data

06:00 AM

Day's Range

229.15
236.85

52 wk Range

75.83
274.95

Overview - ILU - Illumina Inc.

Key Statistics

Valuation

Enterprise Value

33.01B

P/E (Trailing)

‪50.85‬

P/E (Forward)

‪47.70‬

PEG Ratio

‪-6.31‬

Price / Sales (TTM)

‪8.03‬

Price / Book

‪14.48‬

EV / EBITDA

‪32.42‬

Profitability

Profit Margin

‪18.33%‬

Operating Margin

‪21.13%‬

Return on Assets

‪8.66%‬

Return on Equity

‪32.33%‬

Ownership

Shares Outstanding

151.00M

Float

149.77M

Held by Insiders

‪0.21%‬

Held by Institutions

‪106.47%‬

Price stats

Beta

‪1.46‬

50-Day Avg

‪185.36‬

200-Day Avg

‪138.54‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - ILU - Illumina Inc.

News & Analysis

View all news

Market Cap - ILU - Illumina Inc.

Peers - ILU - Illumina Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on FSX.

Profile Summary - ILU - Illumina Inc.

About

Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious…

SectorHealthcare
IndustryDiagnostics & Research
Employees8.60K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.